Fresenius Medical Care AG & Co. KGAA (FMS)
-NYSE 33.79 
0.59(1.72%) May 31, 4:04PM EDT
| Prev Close: | 34.38 |
|---|
| Open: | 33.98 |
|---|
| Bid: | 33.50 x 1300 |
|---|
| Ask: | 37.39 x 400 |
|---|
| 1y Target Est: | 37.00 |
|---|
| Beta: | 0.65 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 33.68 - 34.05 |
|---|
| 52wk Range: | 31.79 - 39.10 |
|---|
| Volume: | 123,746 |
|---|
| Avg Vol (3m): | 160,362 |
|---|
| Market Cap: | 20.73B |
|---|
| P/E (ttm): | 19.94 |
|---|
| EPS (ttm): | 1.69 |
|---|
| Div & Yield: | 0.36 (1.10%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Fresenius Medical Care Prepared to Provide Uninterrupted Care for Dialysis Patients with the Onset of an Active Storm SeasonBusiness Wire(Tue, May 21)
- Fresenius Medical Care Wins Multiple National Awards for Outstanding Patient Case ManagementBusiness Wire(Mon, May 20)
- Fresenius Teams with ApolloMedZacks(Wed, May 15)
- FMS, COO, RMD, THC And HCA, Pushing Health Services Industry Downwardat TheStreet(Wed, May 15)
- Apollo Medical Holdings and Fresenius Medical Care Partner to Improve the Health of ApolloMed ACO Patients with End-Stage Renal DiseasePR Newswire(Tue, May 14)
- Fresenius Medical Care Fights Short-Term Headwindsat Seeking Alpha(Thu, May 9)
- Fresenius Medical Care Wins Modern Healthcare Award for its Innovative Program to Improve Dialysis Patients’ Quality of LifeBusiness Wire(Wed, May 8)
- In A Growth-Starved Sector, Becton Dickinson Rulesat Investopedia(Fri, May 3)
- Fresenius Earnings Lower Y/YZacks(Wed, May 1)
- Fresenius Medical Care AG & Co. KGAA Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, Apr 30)
- Here Are The Reasons To Own Keryx And Why Catalysts Are De-Riskedat Seeking Alpha(Fri, Apr 12)
- Fresenius Teams with HCACOZacks(Tue, Apr 9)
- Heritage California ACO and Fresenius Medical Care Partner to Improve Health of End Stage Renal Disease Patients in Southern CaliforniaBusiness Wire(Mon, Apr 8)
- 3 Stocks Driving The Health Services Industry Higherat TheStreet(Wed, Apr 3)
- FDA posts warning letter sent to Fresenius Medicaltheflyonthewall.com(Tue, Mar 26)
Key Statistics
| Forward P/E (1 yr): | 16.90 |
|---|
| P/S (ttm): | 1.48 |
|---|
| Ex-Dividend Date: | 14-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.81 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.45 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 1.65 |
|---|
Business Summary
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, operates in the field of dialysis care and dialysis products for the treatment of end-stage renal disease.
View More